triplet therapy for metastatic hormone-sensitive prostate cancer
Published 1 year ago • 3.3K plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
4:05
evaluating triplet therapy in metastatic hormone sensitive prostate cancer
-
0:47
systemic triple therapy in metastatic hormone-sensitive prostate cancer
-
1:17
treatment landscape for metastatic hormone-sensitive prostate cancer
-
23:29
auau podcast: treatment for metastatic hormone sensitive prostate cancer
-
3:44
the evolving standard of care for patients with metastatic hormone-sensitive prostate cancer
-
3:12
is the triplet regimen standard of care for metastatic castrate-sensitive prostate cancer?
-
1:41
the role of triplet therapy in men with metastatic castration sensitive prostate cancer
-
13:09
pca commentary: metastatic hormone sensitive prostate cancer (mhspc): many treatment options
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
1:01:45
metastatic hormone sensitive prostate cancer: expert guidance for urologists
-
6:53
perspectives on metastatic hormone-sensitive prostate cancer | bayer
-
1:55
arches trial overview: adt plus enzalutamide for metastatic hormone-sensitive prostate cancer
-
5:16
triplet vs doublet therapy for mcspc
-
2:10
current standards for first-line metastatic hormone-sensitive prostate cancer
-
3:51
metastatic hormone-sensitive prostate cancer (mhspc)
-
1:06
dr. hamid on the progression of therapy for metastatic prostate cancer
-
3:20
radiation therapy for the local treatment of metastatic hormone-sensitive prostate cancer
-
2:12
abiraterone for metastatic, hormone sensitive, prostate cancer
-
1:34
combination therapies for the treatment of prostate cancer